Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
Author: Linnebjerg, H.
Park, S.
Kothare, P.
Trautmann, M.
Mace, K.
Fineman, M.
Wilding, I.
Nauck, M.
Horowitz, M.
Citation: Regulatory Peptides, 2008; 151(1-3):123-129
Publisher: Elsevier Science BV
Issue Date: 2008
ISSN: 0167-0115
Statement of
Helle Linnebjerg, Soomin Park, Prajakti A. Kothare, Michael E. Trautmann, Kenneth Mace, Mark Fineman, Ian Wilding, Michael Nauck and Michael Horowitz
Abstract: <h4>Objectives</h4>To evaluate the effect of exenatide on gastric emptying (GE) in type 2 diabetes using scintigraphy.<h4>Methods</h4>Seventeen subjects with type 2 diabetes participated in a randomized, single-blind, 3-period, crossover study. In each 5-day period, 5 or 10 microg exenatide or placebo was administered subcutaneously BID. Oral antidiabetic treatments were continued. The presence of cardiac autonomic neuropathy was assessed during screening. On day 5, after the morning dose, subjects consumed a 450-kcal breakfast containing (99m)Tc-labeled eggs and (111)In-labeled water, and GE was measured by scintigraphy. Plasma glucose and insulin, perceptions of appetite, and plasma exenatide were also quantified.<h4>Results</h4>Exenatide slowed GE of both solid and liquid meal components [solid (T(50)(90% confidence interval [CI]); placebo, 60(50-70) min; 5 microg exenatide, 111(94-132) min; 10 microg exenatide, 169(143-201) min; both P<0.01); liquid (T(50)(90% CI), placebo, 34(25-46) min; 5 microg exenatide, 87(65-117) min; 10 microg exenatide, 114(85-154) min; both P<0.01)]. GE was not different between subjects with cardiac autonomic neuropathy (n=7), compared with those without (n=10) (P>/=0.68). Exenatide reduced postprandial glucose (area under the curve [AUC((0-6 h))]) by 69-76% and peak insulin (C(max)) by 84-86% compared with placebo. There was an inverse relationship between the postprandial rise in glucose (AUC((0-3 h))) and GE (solid T(50), r=-0.49, P<0.001).<h4>Conclusions</h4>Exenatide slows GE substantially in type 2 diabetes, which could be an important mechanism contributing to the beneficial effect of exenatide on postprandial glycemia.
Keywords: Diabetes; Gastric emptying; Exenatide; Scintigraphy
DOI: 10.1016/j.regpep.2008.07.003
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.